Section Arrow
UPC.NASDAQ
- Universe Pharmaceuticals Inc
Quotes are at least 15-min delayed:2025/12/30 17:58 EST
After Hours
Last
 3.99
+0.025 (+0.63%)
Bid
3.95
Ask
4.17
High 3.99 
Low 3.95 
Volume 976 
Regular Hours (Closed)
Last
 3.965
-0.455 (-10.29%)
Day High 
4.19 
Prev. Close
4.42 
1-M High
7.2 
Volume 
44.65K 
Bid
3.95
Ask
4.17
Day Low
3.95 
Open
4.19 
1-M Low
3.53 
Market Cap 
2.49M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.02 
20-SMA 4.03 
50-SMA 4.13 
52-W High 27.152 
52-W Low 2.51 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-255.68/--
Enterprise Value
4.63M
Balance Sheet
Book Value Per Share
97.96
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
23.02M
Operating Revenue Per Share
61.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CGCCanopy Growth Corp1.16-0.05-4.13%-- 
After Hours 1.16 0 0.00%
HIMSHims & Hers Health33.04-1.06-3.11%64.02PE
After Hours 32.9 -0.14 -0.42%
VTRSViatris12.54+0.17+1.37%227.2PE
After Hours 12.54 0 0.00%
TLRYTilray Brands Inc.9.02-0.24-2.59%-- 
After Hours 9.01 -0.01 -0.11%
IXHLIncannex Healthcare0.3601-0.0099-2.68%-- 
After Hours 0.364 +0.0039 +1.08%
Industry overview quotes are at least 15 minutes delayed
Business Description
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.